$CTSH

US Suspends Cognizant’s PERM Filings, Who's Next?

The US Department of Labor suspended Cognizant's PERM filings, citing potential fraud in H-1B and PERM programs. The investigation involves the White House Fraud Task Force. Cognizant's new filings are blocked, but existing approvals and H-1B visas remain unaffected. This action may increase scrutiny on other IT firms like TCS, Infosys, and Wipro.

Original reporting
Published Sep 8, 2026, 4:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 5:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
US Suspends Cognizant’s PERM Filings, Who's Next? — source image
Decision brief

The 30-second read

$CTSHBearishHigh
01

Why it matters

Cognizant faces immediate operational risk and potential investor sentiment decline due to the suspension of new PERM filings.

02

Market read

Regulatory action against a major IT services provider could trigger sector-wide risk reassessment and affect related stocks.

03

What to watch

The action does not affect existing H‑1B visas or approved PERM cases, and the company may shift hiring to domestic talent.

Relevance 8/10Novelty 8/10Timing: today

Background

The U.S. Department of Labor has been increasing enforcement of H‑1B and PERM visa programs, targeting large IT service providers.

Company-level read

Ticker impact

$CTSHBearishHigh confidence
Context

US Labor Department suspended Cognizant's PERM visa filings, indicating regulatory scrutiny and potential hiring restrictions.

Expected impact

Potential short-term downside pressure; price may dip 3-5% as investors reassess risk.

Evidence & confidence

Enforcement action is a material regulatory risk for a large IT services firm heavily reliant on H‑1B visas.

Market effects

May increase compliance costs and hiring constraints for US IT services firms, prompting broader sector caution.

Potential ripple effect on Indian IT exporters as U.S. visa scrutiny intensifies.

Highlights heightened regulatory focus on immigration programs affecting multinational tech staffing.

Counterpoint

If Cognizant can resolve the issue quickly, the suspension may be short-lived and price impact limited.

Key entities

  • Cognizant

    Global IT services firm listed on NASDAQ (CTSH).

  • U.S. Department of Labor

    Federal agency enforcing labor and immigration laws.

Related articles

$CTSHMedAI 8/10

Cognizant Stock Falls 3.8%—Is CTSH Cheap at 10 Times Earnings?

Cognizant (CTSH) shares fell 3.8% to $59.92, trading at 10.4x its 2026 EPS forecast. Q2 revenue rose 4.5% to $5.48B, with adjusted EPS up 4.6% to $1.37. Bookings declined 6% YoY, raising concerns. Management revised revenue growth guidance to 4.0%-5.5% and raised EPS guidance to $5.70-$5.82. Investors weigh AI's impact on growth and margins.

$CTSHMedAI 8/10

US halts Cognizant's green-card filings amid Trump's visa fraud crackdown

The US has suspended Cognizant's permanent labor certification filings amid a visa fraud probe. The move is part of a broader crackdown by the Trump administration. Cognizant, a major H-1B sponsor, faces scrutiny over alleged fraud in its visa programs. The suspension bars new PERM applications until the investigation concludes. According to US Citizenship and Immigration Services, Cognizant had 3,510 H-1B visa approvals as of June 30, down from 9,413 in 2020.

$CTSHMedAI 8/10

Cognizant's AI Gamble: What Nearshore Must Learn

Cognizant reported Q2 2026 revenue growth of 4.5%, down from Q2 2025, but beat peers and met guidance. Bookings fell 6% YoY. The company raised full-year EPS guidance to $5.70-$5.82, and its stock surged 41.81% in a month. Cognizant cited AI-led demand and partnerships with Google Cloud and Anthropic.

$CTSHMed

Anthropic Is Only Part of the Story. Cognizant Has a Much Bigger AI Plan.

Cognizant (CTSH) trades at a discount versus its historical valuation, with forward GAAP P/E of 8.31x and P/S of 0.97x. In Q2, it reported EPS $1.37 vs $1.38 expected, 4.5% revenue growth, and $459M free cash flow. Management guided Q3 growth 3.8%-5.3% YoY and FY EPS to $5.76 midpoint. Guggenheim cut its price target to $65 but kept a Buy; analysts’ mean target is $60.12.